Efficacy and safety of orforglipron in adults with body mass index of 27 to less than 30 kg/m2 and adiposity-related complications: A post hoc analysis of the ATTAIN-1 trial

Obesity Pillars · Elsevier

Аннотация

Publication date: December 2026 Source: Obesity Pillars, Volume 20 Author(s): Jaime P. Almandoz, Alexander Dimitri Miras, Matthias Blüher, Pedro Orozco Del Pino, Donna Mojdami, Rachel L. Batterham, Kevin Trice, Benjamin Goebel, Fatih Tangi

Читать у издателя →

Похожие статьи